Delivery Order SPE2DB25D7056-SPE2DB25FTMMH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100-count) with a ceiling value of $3,690.82. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is scheduled for ultimate completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,562.14 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on October 20, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's substantial...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Dexmethylphenidate ER 10 mg capsules in a quantity of 100 units at a ceiling value of $3,265.34. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements through open competition. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.20 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 25 mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed price terms and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 5 mg capsules (100-count) valued at $2,275.58 under a firm fixed price contract type. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025. No set-aside designation was used for this procurement, indicating the award resulted from open competition. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,684.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). This was a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. As a child order under a larger contract vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100-count) with a ceiling value of $1,202.32. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 7, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,172.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMMHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,282.75 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 5 mg capsules (100-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating the award was made through competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving entities including the Defense Health Agency and U.S. Coast Guard. The current delivery order for dexmethylphenidate, a controlled-release attention-deficit hyperactivity disorder medication, represents routine pharmaceutical fulfillment within this larger strategic contract vehicle designed to ensure consistent pharmaceutical availability across the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 6/2/25 |